2021, Number 1
<< Back Next >>
Med Int Mex 2021; 37 (1)
Doctor… am I going to die?
Ruiz-Argüelles GJ, Ruiz-Delgado GJ
Language: Spanish
References: 7
Page: 5-7
PDF size: 285.77 Kb.
Text Extraction
No abstract.
REFERENCES
Cruz-Mora A, Murrieta-Álvarez I, Olivares-Gazca JC, León-Peña A, et al. Up to half of patients diagnosed with chronic lymphocytic leukemia in México may not require treatment. Hematology 2020; 25: 156-159. doi. 10.1080/16078454.2020.1749473.
Murrieta-Álvarez I, Steensma DP, Olivares-Gazca JC, Olivares-Gazca M, et al. Treatment of persons with multiple myeloma in underprivileged circumstances: real-world data from a single institution. Acta Haematol 2020; 143 (6): 552-558. doi.10.1159/000505606.
Masaoka H, Ito H, Yokomizo A, Eto M, et al. Potential overtreatment among men aged 80 years and older with localized prostate cancer in Japan. Cancer Sci 2017; 108: 1673-80. doi. 10.1111/cas.13293.
Lyu H, Xu T, Brotman D, Mayer-Blackwell B, et al. Overtreatment in the United States. PLoS One 2017; 6: 12:e0181970. https://doi.org/10.1371/journal. pone.0181970.
Ruiz-Argüelles GJ. A new breed in the teaching of medicine: paid lecturers, trainers or speakers. Acta Haematol 2016; 135: 191-2. https://doi.org/10.1159/000443199.
Ruiz-Argüelles GJ. Outpatient programs of myeloablative chemotherapy, autologous and allogeneic bone marrow transplantation. Haematologica 2000; 85: 1233.
Ruiz-Argüelles GJ. Factors involved in the selection of treatment in patients with hematological malignancies. Acta Haematol 2019; 141: 54. doi. 10.1159/000493569.